Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk Cohort

NCT05384535 is registered in ClinicalTrials.gov with Northwell Health as lead sponsor.

NCT NCT05384535
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05384535 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk Cohort
Lead sponsor
Northwell Health
Phase
Not applicable
Overall status
Recruiting
Start date
August 15, 2022
Completion date
October 31, 2028
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

magnetic resonance imaging, population at risk, prostate cancer